Conquering Diseases

Study Of An Investigational Drug For Social Performance Of Adolescents With Autism Spectrum Disorder

Description

Seeking teens aged 13-17 with autism spectrum disorder for a study of whether an investigational drug affects the level of the chemical GABA in the brain and if it improves social performance.

Overview

Participants in this study will have about 6-7 office visits, three of which could take up to 6 hours. The investigational drug, which has been FDA approved for other medical conditions but not autism spectrum disorder, will be taken by mouth three times a day for 8 weeks.

What we're hoping for

We are studying whether an investigational drug helps improve social performance for teens with autism spectrum disorder.

Additional Information

ClinicalTrials.gov Identifier: NCT05063656

 Principal Investigator

David  Cochran, MD

UMass Memorial Health Care

 Study Contact

Arline  Mata

arline.mata@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989